๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vascular targeted therapies in oncology

โœ Scribed by Dietmar W. Siemann; Michael R. Horsman

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
295 KB
Volume
335
Category
Article
ISSN
0302-766X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Targeted therapy in pediatric and adoles
Targeted therapy in pediatric and adolescent oncology
โœ Mark L. Bernstein ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 946 KB

## Abstract Cancers in children and adolescents are fortunately infrequent. Overall, cure rates are good, approximately 80%, although this varies by histology and stage. Targeted therapies aim to improve efficacy and decrease toxicity by more specifically affecting malignant cells or their supporti

Cell therapies in neuro-oncology
Cell therapies in neuro-oncology
โœ S. Pellegatta; G. Finocchiaro ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› Springer Milan ๐ŸŒ English โš– 55 KB
Molecular targeted therapies in hepatoce
Molecular targeted therapies in hepatocellular carcinoma
โœ Josep M. Llovet; Jordi Bruix ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 647 KB

Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with several genomic alterations. There is evidence of aberrant activation of several signaling cascades such as epidermal growth factor receptor (EGFR), Ras/extracellular signal-regulated kinase, phosphoinositol 3-kinase/mammalian

Novel targeted therapies in inflammatory
Novel targeted therapies in inflammatory breast cancer
โœ Massimo Cristofanilli ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 84 KB ๐Ÿ‘ 2 views

## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T